0001144204-16-077036.txt : 20160126
0001144204-16-077036.hdr.sgml : 20160126
20160126171202
ACCESSION NUMBER: 0001144204-16-077036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160126
FILED AS OF DATE: 20160126
DATE AS OF CHANGE: 20160126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001208261
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521841431
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 940
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-440-9310
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 940
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: EPICEPT CORP
DATE OF NAME CHANGE: 20021129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Teper Daniel Gedeon
CENTRAL INDEX KEY: 0001584822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36602
FILM NUMBER: 161362357
MAIL ADDRESS:
STREET 1: C/O IMMUNE PHARMACEUTICALS INC.
STREET 2: 777 OLD SAW MILL RIVER RD.
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
v429748_form4.xml
FORM 4
X0306
4
2016-01-26
0
0001208261
IMMUNE PHARMACEUTICALS INC
IMNP
0001584822
Teper Daniel Gedeon
C/O IMMUNE PHARMACEUTICALS INC.
430 EAST 29TH STREET, SUITE 940
NEW YORK
NY
10016
1
1
1
0
CEO
Common Stock
2016-01-26
4
P
0
42000
0.5911
A
4810905
D
The transaction reported in this line item was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2015.
/s/ Daniel G. Teper
2016-01-26